Orally Efficacious NR2B-Selective NMDA Receptor Antagonists
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (4) , 697-700
- https://doi.org/10.1016/s0960-894x(02)01061-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Novel N1-(benzyl)cinnamamidine derived NR2B subtype-selective NMDA receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2003
- 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2002
- NR2B Selective NMDA Receptor AntagonistsCurrent Pharmaceutical Design, 2002
- NMDA receptor antagonists as analgesics: focus on the NR2B subtypePublished by Elsevier ,2001
- Potential and Current Use of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of AgingDrugs & Aging, 2001
- (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate ResponsesJournal of Medicinal Chemistry, 1995
- Intravenous Infusion of the NMDA Antagonist, Ketamine, in Chronic Posttraumatic Pain with AllodyniaClinical Neuropharmacology, 1995
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995
- Developmental and regional expression in the rat brain and functional properties of four NMDA receptorsPublished by Elsevier ,1994
- Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicingBiochemical and Biophysical Research Communications, 1992